Osborne-Mendel rats simultaneously develop cardiac and renal dysfunction, left atrial thrombosis, peripheral artery

Makoto Asahina1, Hideki Matsumoto1, Yoshitaka Yasuhara1

  • 1Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., 26-1, Muraoka-Higashi 2chome, Fujisawa, Kanagawa, 251-8555, Japan.

Insights

The Osborne-Mendel rat, fed a high-cholesterol diet, spontaneously develops cardiovascular disease (CVD) and renal dysfunction. This atherosclerosis-prone rat strain offers a novel model for studying chronic kidney disease (CKD) and CVD comorbidities.

Area of Science:

  • Nephrology
  • Cardiology
  • Animal Models

Background:

  • Chronic kidney disease (CKD) and cardiovascular disease (CVD) are closely linked, but the underlying mechanisms remain unclear.
  • Developing effective therapeutic strategies requires experimental models that accurately mimic the complex pathophysiology of these co-occurring conditions.

Purpose of the Study:

  • To identify and validate a novel animal model that spontaneously exhibits both cardiac and renal dysfunction, along with cardiovascular events.
  • To establish a suitable model for pre-clinical testing of pharmacological therapies targeting CKD and CVD.

Main Methods:

  • Evaluation of 16 inbred rat strains fed a high-cholesterol diet.
  • Assessment of cardiovascular parameters including aortic aneurysm, dissection, peripheral artery occlusion, left atrial thrombosis, cardiac contractility (dP/dt), hypertension, and endothelial function.
  • Analysis of renal function markers such as urinary albumin excretion.
  • Comparison of Osborne-Mendel (OM) rats with F344 rats.

Main Results:

  • Osborne-Mendel (OM) rats were identified as atherosclerosis-prone and exhibited premature death on a high-cholesterol diet.
  • OM rats simultaneously developed aortic aneurysm, dissection, peripheral artery occlusion, and left atrial thrombosis.
  • OM rats displayed impaired cardiac contractility, renal dysfunction (increased albuminuria), mild hypertension, decreased endothelial function, and enhanced coagulation/platelet aggregation compared to F344 rats.

Conclusions:

  • The OM rat is a novel spontaneous animal model that concurrently demonstrates cardiac and renal dysfunction, and cardiovascular disease events.
  • This model serves as a valuable tool for pre-clinical evaluation of pharmacological treatments for CKD and CVD.
  • The OM rat model may offer new insights into therapeutic targets and pathways for managing comorbid CKD and CVD.